Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results

Clinical trials have consistently shown the benefits of beta-blocker treatment in patients with chronic heart failure (HF). As a result, bisoprolol, carvedilol, and metoprolol succinate are now indicated for the treatment of all patients with chronic HF who do not have major contraindications. Bisop...

Descripción completa

Detalles Bibliográficos
Autores principales: Metra, Marco, Nodari, Savina, Bordonali, Tania, Milani, Patrizia, Lombardi, Carlo, Bugatti, Silvia, Fontanella, Benedetta, Verzura, Giulia, Danesi, Rossella, Dei Cas, Livio
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374926/
https://www.ncbi.nlm.nih.gov/pubmed/18472978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374926/
https://www.ncbi.nlm.nih.gov/pubmed/18472978

Ejemplares similares